A Multicenter, Retrospective, Observational Study to Evaluate the Efficacy of Belimimab in Patients with Systemic Lupus Erythematosus (SLE) in Clinical Practice Setting in the United States.

Trial Profile

A Multicenter, Retrospective, Observational Study to Evaluate the Efficacy of Belimimab in Patients with Systemic Lupus Erythematosus (SLE) in Clinical Practice Setting in the United States.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Aug 2015

At a glance

  • Drugs Belimumab (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Therapeutic Use
  • Acronyms OBSErve US
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 27 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top